Early and late AD follow different patterns of decline or have symptoms appearing at different times, so understanding the different progressions of deterioration is difficult. Clearer maps of symptomatic progression and rate of decline for early and late AD would increase the opportunity for preventative medicine and help in treatment. Are there drugs that regularize amyloid metabolism ? What is the role of glutamate in the brain?